STIMULAN® certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics STIMULAN® certified to resolve infection and reduce the need for secondary surgery STIMULAN® is the only calcium matrix antibiotic carrier certified for use in bone and surrounding soft tissue Keele, UK, 5 February 2026 – Biocomposites, an international medical devices company that […]
Biocomposites launches SYNICEM™ spacers in Canada Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has launched its SYNICEM™ hip, knee and shoulder preformed spacers in Canada. It follows the launch of the same products in the US last October. Biocomposites, […]
Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to the BioInnovation Institute (BII), a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its activities into […]
STIMULAN® Rapid Cure can now be used with both a wider range of antibiotics and also with antifungals in India STIMULAN® Rapid Cure can be placed in bone and surrounding soft tissue to assist in wound healing and treatment of infection Keele, UK, 25 November 2025 – Biocomposites, an international medical devices company that engineers, […]
👥London Life Sciences Week 2025 The busiest week in European life sciences is approaching and Optimum and Catalyst Advisors are here to help you maximise your week. Download our events schedule here to plan ahead, connect smart, and make every moment count! If you have any additional events that you would like to be included, […]
